Hair follicle (HF) epithelium is an ideal target for gene therapy for many systemic diseases as well as skin disorders, because HFs are located at the surface of the body and are readily accessible without causing undue damage to the integument. In addition, HFs have an obvious potential to be used to produce local and systemic proteins.
To establish a therapeutic gene transfer system for HFs, many researchers have tried using a variety of methods. [1] [2] [3] [4] [5] Intradermal injection of purified DNA, topical application of liposome-DNA complexes, high pressure gene gun and virus infection have been used to transfer genes into HFs. In order to obtain stable and persistent transgene expression and maximize the beneficial transgene therapeutic effects, the stem cell population should preferentially be targeted.
The HF stem cells have been reported to lie in the HF bulge region. [6] [7] [8] [9] Many cells derived from the bulge contain colony-forming cells, 10, 11 and have a slow cycling, quiescent nature. 12 Transplantation studies and bromodeoxyuridine (BrdU) labeling experiments suggest that bulge cells possess the ability to differentiate into any kind of cutaneous epithelial cell, including the sebaceous gland and interfollicular epidermal keratinocytes. [12] [13] [14] [15] [16] The final goal of this study was to develop an efficient gene transfer system targeted for skin epithelial stem cells located in the bulge region. To establish optimal, persistent and stable expression of the transgene, a recombinant retroviral system was adopted because of its high gene transfer and integration efficiency, 17 although the transduction of retrovirus vector requires cells to be undergoing replication at the time of infection. 18 Thus, it has been difficult to introduce genes directly into the stem cells in vivo, because the stem cell population in the HF epithelium and the epidermis is a relatively small population and stem cells are relatively slowly cycling. 12 At first, we established a HF stem cell-rich culture system using cells from rat vibrissa bulge cells ( Figure  1a ) and evaluated the nature of these cells. In vitro, primary cultures of bulge-derived cells formed significantly more colonies than arose from outer root sheath cells (ORS) (Figure 1b) as has been described previously. 10 Furthermore, the proliferation rate of cells from the bulge in long-term culture was greater than that of ORS cells (Figure 1c ) and bulge-derived cells retained the ability to form colonies after three passages. These results confirmed the previous report 16 that bulgederived cells display self-renewal characteristics of stem cells even if they are removed from their native niche and induced to proliferate in culture.
In order to obtain transcriptional profiles of bulgederived cells, we carried out microarray analysis ( Figure  1d and Supplementary Table 1 ). In stem cell-rich cultures from the bulge, 78 mRNA species were upregulated more than twofold, and 88 mRNA species were downregulated more than twofold in comparison with cultured ORS cells. Stem cell-rich bulge-derived cells showed upregulated expression of several genes including, Col2a1, Igfbp3, Igfbp6 and Fgf13, which have been already reported to be upregulated in stem cells in the previous reports (Figure 1d ). [14] [15] [16] These results further confirmed that cultured bulge-derived cells contained the HF stem cell population. In the present study, none of CD34, b1-integrin or S100a4, all of which were reported previously as HF stem cell markers, [14] [15] [16] was upregulated in bulge-derived cells. These differences might be caused by different states that the putative stem cells are maintained in. Thus, the putative stem cell markers, CD34, b1-integrin and S100a4, may be associated with stem cells in a quiescent state in the bulge niche. Conversely, genes that were upregulated in both quiescent and proliferating states may prove to be better marker molecules for stem cells in their proliferate state.
Subsequently, we regenerated an entire HF epithelium and interfollicular epidermis using cultured bulgederived cells. The cultured bulge-derived cells including HF stem and progenitor cells were thoroughly mixed with neonatal rat vibrissa dermal papilla (DP) cells and this cell slurry engrafted into a silicone chamber implanted on to the backs of SCID mice as previously reported. 19 At 4 weeks after transplantation, the grafts containing bulge and DP cell mixtures exhibited tufts of hairs as well as complete interfollicular epidermis (Figure 2a) .
To evaluate whether the reconstituted skin and appendages were truly derived from bulge cells, we grafted the bulge cells from vibrissa of adult Rosa 26 mice that constitutively express the lacZ reporter gene under the control of an SV40 promoter, mixed with rat DP cells. The graft was harvested after 4 weeks and then stained for b-galactosidase. The entire epithelium including HF, sebaceous gland and the interfollicular epidermis was b-galactosidase-positive and the DP cells were completely devoid of b-galactosidase staining ( Figure 2b ). These results indicated that the cultured cells derived from the bulge region retained their multipotent potential to create multiple epithelial skin and appendages ( Figure 2c ). In addition, adult tissuederived cells also maintained this ability.
Hematoxylin and eosin (H&E) staining of frozen sections of reconstituted HFs showed that the morphology of the reconstituted HFs was very similar to that of normal rat pelage follicles (Figure 2d ), although the dermis was more tightly packed with fibroblasts than is usually seen in normal rat skin. The reconstituted HFs were also randomly orientated in contrast to the uniform orientation of normal skin (data not shown).
Scanning electron microscopic observation of the reconstituted hairs revealed that the hair cuticle pattern was similar to that of normal rat vibrissa from where the cells were initially derived (Figure 2e and f), although reconstituted hairs were thinner than normal ones. Transmission electron microscopic observation revealed normal morphology of HFs. The reconstituted HFs displayed a normal inner root sheath (IRS), with sheath cuticle (Cs), Huxley's (Hu) and Henle's (He) layers readily identified by their electron-dense trichohyalin granules ( Figure 2g ) and an ORS ( Figure 2h ).
As a next step, we performed HF stem and progenitor cell-targeted gene transfer using a retrovirus vector with enhanced green fluorescent protein (EGFP) or LacZ as a marker. Cultured bulge-derived cells were infected with retrovirus carrying the EGFP gene, and 30-40% of cells expressed EGFP 4-days after infection (data not shown). EGFP-positive colonies were still observed after the third passage (Figure 3a ). This result confirmed that the transgene had been successfully introduced into a subset of cells with a colony-forming ability (that were assumed to be putative stem cells). Rats or mice were killed by carbon dioxide asphyxiation. The upper lip containing the two vibrissa pads were cut out and its inner surface was exposed. Each selected vibrissa was then microdissected under a binocular microscope. The subcutaneous fat and connective tissue surrounding the vibrissa capsule was then carefully removed. The vibrissa was then pulled away from the pad by holding its neck with fine forceps. (b) The growth of bulge-derived cell colonies (upper) and outer root sheath (ORS) cell colonies (lower) from rat vibrissa. The follicle was cut into four fragments. From the bulbar side, the first transverse cut was made just above the hair bulb, and the second was made at the site of insertion of the nerve fibers, which is proximal to the site of inferior enlargement of the outer sheath. The third cut was made just below the sebaceous glands. The lower part of the capsule was then carefully prized away from the bulb; special care was taken at this stage to leave the dermal papilla in place. ORS cells were isolated from second lowest part and bulge cells were isolated from third lower part of the vibrissa follicles. Each fragment was then transferred into dispase solution (Godoshusei Ltd) and was incubated for 1 h at 41C. The epithelial cells were then teased away from the thin dermal sheath with fine needles. A 0.25% solution of trypsin was then added and the cell and HF fragments were further incubated for 10 min at 41C. Equal numbers of live cells were plated onto mitomycin C-treated 3T3 fibroblasts in Defined-Keratinocyte Serum Free Medium (Invitrogen). The cells were cultured for 1 week in vitro and either fixed and stained with Rhodamine B for visual inspection or; (c) passaged for long term survival and growth analysis. (d) Selected genes whose expression was upregulated in HF bulge cells. For microarray analysis, isolated cultured cells derived from rat vibrissae bulge or ORS were collected. We used 5 mg of total RNA from each cell population as a starting material, and no amplification steps beyond mRNA transcription were performed to minimize the chance of losing accurate representations of mRNA levels. The mRNA products were hybridized to a Rat oligo microarray (Agilent). All protocols and data analysis were conducted according to the manufacturer's manual. The genes whose upregulated expression had been reported previously were denoted by asterisks (*).
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Finally, we reconstituted HFs and interfollicular epidermis in vivo from cultured bulge-derived cells. At first, we tried to follow the behavior of transplanted cells using a retrovirus harboring EGFP gene as a marker, because GFP was generally used in several reports as a real-time marker in the living mice.
19-21 However, we could not demonstrate the required signals in vivo, although we could detect the signals in the differentiated epidermal regions that is stratum corneum and IRS cells from skin tissue sections. We speculate that the reason we could not obtain sufficient EGFP signal in vivo or from epidermal sections might be that scattered or diffuse EGFP cannot generate a sufficiently strong detectable signal in vivo or tissue sections. Indeed, 1 month after transplantation, the in vivo EGFP expression was diffuse and its signal was only weakly detected. Thus, to demonstrate the transgene expression clearly, we decided to use cultured bulge-derived cells harboring the retrovirus vector-LacZ marker as follows. Cultured SD rat vibrissa bulge-derived cells were infected with Figure 2 Intact, mature HFs were reconstituted from the cultured, bulge-derived stem cells. (a) Hairs that were reconstituted from bulgederived cells and rat vibrissa dermal papilla cells. Bulge cells were isolated and cultured in Defined-Keratinocyte Serum Free Medium (Invitrogen). Primary dermal papilla cells were microdissected from vibrissae of new born SD rats (Clea) and cultured in Amino MAX medium (Invitrogen). Engraftment was performed as previously described. 22 Equal numbers of dermal papilla cells and epithelial cells were combined at a final density of 2-3 Â 10 6 cells and these cells were injected into a silicon chamber attached to the back of an anesthetized SCID mouse (Clea). After 1 week, the wounds had healed, and chamber tops were removed. Hair typically appeared 2-3 weeks thereafter. (b) X-gal staining of the reconstituted skin demonstrated that all the epithelial components were produced from the bulge-derived cells from Rosa 26 mice. Equal numbers of rat dermal papilla cells and Rosa 26 mouse bulge cells were injected into a silicon chamber attached to the back of an anesthetized SCID mouse (Clea). After 4 weeks, the reconstructed skin was immediately frozen in OCT compound (Sakura Finetechnical), and cut at a thickness of 6 mm. To detect the transgene product expression, sections were fixed for 1 h in 0.2% glutaraldehyde and stained en face with 1 mg/ml X-gal in 0.1 M sodium phosphate buffer (pH 7.5) containing 5 mM K 3 Fe (CN) 6 , 5 mM K 4 Fe (CN) 6 , 1 mM MgCl 2 , 0.02% NP-40 and 0.01% sodium deoxycholate at 371C for 5 h. Sections were counterstained with H&E. The cultured bulge-derived cells differentiated to all epithelial cell types within the cutaneous epithelia. Epi; Epidermis, SG; Sebaceous gland, DP; Dermal papilla cells. (c) Schematic view of HF stem cell behavior during the skin reconstitution processes. Bulge-derived cells differentiate into all the epithelial components. Epi; Epidermis, SG; Sebaceous gland, DP; Dermal papilla cells, Bu; bulge (d) H&E staining of reconstituted HF showed normal bulb region morphology in the reconstituted HF. (e and f) Scanning electron microscopy of reconstituted hair shaft; hairs for scanning electron microscopy (EM) analysis were fixed in 5% glutaraldehyde in PBS at room temperature for 30 min, processed using standard techniques, and visualized using a HITACHI S-4500 electron microscope. (e) The reconstituted hair shaft was demonstrated intact, mature shaft morphology similar to a normal rat vibrissa (f). (g and h) For transmission EM, fresh biopsies of engrafted skin were fixed in 2% glutaraldehyde solution, postfixed in 1% OsO 4 , dehydrated, and embedded in Epon 812. All the samples were ultrathin sectioned at a thickness of 70 nm, and stained with uranyl acetate and lead citrate. Photographs were taken using a Hitachi H-7100 transmission electron microscope. A longitudinal section of the inner layers of a reconstituted HF (g) exhibited the Henle's (He) layer flanked by the trichohyalin (Th)-rich Huxley's (Hu) layer, and the thin IRS cuticle (Cs). The hair shaft (HS) was internal to the IRS. In the outer layers (h), there were normal ORS cells. Scale bars: 50 mm (b and d), 15 mm (f), 3 mm (g and h).
Hair follicle stem cell gene transfer Y Sugiyama-Nakagiri et al Hair follicle stem cell gene transfer Y Sugiyama-Nakagiri et al retrovirus carrying the LacZ gene under the CMV promoter. At 4 or 5 days after infection, cells were grafted as previously described. We did not use FACS to enrich the cells expressing transgene because we had not used the EGFP system as a transgene expression marker. Hair shaft budding was detected at 4 weeks after grafting and these mice were killed. Transgene expression in the HF epithelium and the epidermis was analyzed by X-gal histochemical staining in tissue sections from the reconstituted skin. b-Gal-positive keratinocytes were found in several parts of the de novo reconstituted skin including the HF epithelium, the sebaceous glands and the interfollicular epidermis (Figure 3b) . In HFs, b-galpositive cells could be observed in any area of the HF, that is ORS, IRS and matrix (Figure 3c) . b-Gal expression was also seen in the basal cells and differentiated cells of the sebaceous gland (Figure 3d) . The clonal pattern of b-gal-positive epidermal keratinocytes was indicative of epidermal proliferation units (EPU) (Figure 3e ). These results showed that any epithelial skin element including HFs, sebaceous glands and the interfollicular epidermis could be reconstituted from bulge-derived stem or progenitor cells carrying the LacZ transgene. We then followed the fate of these gene-transduced cells. We observed the reconstituted HFs, sebaceous glands and interfollicular epidermis 2 months after transplantation. b-Gal-positive cells were seen in the reconstituted tissues and the areas covered by the b-gal-positive cells appeared to expand compared with the skin 1 month after transplantation (Figure 3f-h ). Furthermore, we were able to detect the transgene expression in the reconstituted tissues as late as 6 months after transplantation (Figure 3i-k) .
To summarize the data in the present study, we have obtained a stem cell pool from the HF bulge of not only neonatal but also adult mice and rats and performed gene transfer into the cultured bulge-derived cells. We have succeeded in reconstituting HFs from these cultured bulge-derived cells harboring the transgene. In addition, the transgene was expressed in all reconstituted epithelial skin compartments including the HF epithelium, sebaceous gland epithelium and the epidermis for at least 6 months after transplantation.
In the present HF reconstitution study, we did not use EGFP as a transgene expression marker. Thus, we were unable to use FACS to enrich the cells expressing transgene. For practical application of this system to gene therapy, using FACS to maximize the percentage of targeted, transgene expressing cells would be important, especially if targeted cells are at a growth disadvantage relative to wild type cells.
HF units have the potential to become a source of proteins for possible use in protein therapy. In addition, HF stem cells are able to provide cells that are able to form the vast majority of the epidermis. Thus, HFtargeted gene therapy might be applicable not only to skin diseases, but also to systemic diseases, for example, hormone deficiency.
Therefore, a 'hair follicle stem cell-targeted gene transfer and reconstitution system' may enable the stable expression of transgene in any part of the cutaneous epithelium and provide longstanding therapeutic benefits if used for gene therapy. In addition, this system has the potential to produce a reliable means for genefunction analysis and gene therapy. We have now applied this system to a clinical setting and the results are currently under analyses in our laboratory.
